Physician profile
Srikanth Mahavadi
NPI 1487610341
$12,113.96
in general payments reported to CMS, 2019-2025
30 companies · $3,098 in 2025
The $3,098 reported for 2025 was more than what 97% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,090 · 2020: $1,561 · 2021: $1,954 · 2022: $856 · 2023: $2,288 · 2024: $1,267 · 2025: $3,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,705 · Travel and Lodging: $2,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,705.01 |
| Travel and Lodging | $2,947.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,500.82 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $2,495.16 | 2019-2025 | Grafix Pl, Grafix, Stravix |
| Kci USA, INC. | $1,688.92 | 2021-2023 | 3m Cavilon, V.A.C. Veraflo, Prevena |
| Fortis Surgical, LLC | $1,079.00 | 2020-2024 | |
| Paratek Pharmaceuticals, INC. | $802.63 | 2019-2024 | Nuzyra |
| Lifenet Health | $634.37 | 2023-2025 | Theragenesis Wound Matrix |
| Organogenesis INC. | $468.58 | 2019-2025 | Affinity, Novachor, Puraply Wound Matrix |
| Horizon Therapeutics Plc | $348.13 | 2019-2021 | |
| Abbvie INC. | $323.49 | 2021-2025 | |
| Convatec INC. | $314.51 | 2022-2025 | |
| Celularity INC. | $267.00 | 2019 | |
| Stryker Corporation | $213.36 | 2023-2024 | Bioskin, Viaflow, Variax |
| Melinta Therapeutics, LLC | $158.59 | 2019-2025 | Kimyrsa, Orbactiv, Rezzayo |
| Keswick Pharmaceuticals LLC | $155.52 | 2019 | |
| Ani Pharmaceuticals, INC. | $117.40 | 2025 | Purified Cortrophin Gel |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $97.96 | 2019-2023 | |
| Misonix INC | $96.61 | 2019-2021 | |
| Osteomed LLC | $96.38 | 2019 | |
| Next Science LLC | $57.53 | 2023 | Xperience, Blastx, Surgx |
| Bsn Medical INC | $39.26 | 2025 | |
| Allergan, INC. | $24.16 | 2020 | |
| Depuy Synthes Sales INC. | $22.33 | 2023 | N/A |
| Ets Wound Care LLC | $16.27 | 2024 | Mirragen Advanced Wound Matrix |
| Merck Sharp & Dohme LLC | $16.26 | 2019 | |
| Urgo Medical North America, LLC | $15.50 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| In2bones USA, LLC | $14.54 | 2022 | |
| Alfasigma USA, INC. | $14.18 | 2021 | |
| Nabriva Therapeutics, Plc | $12.17 | 2022 | |
| Reprise Biomedical, INC. | $11.67 | 2025 | Miro3d |
| Linvatec Corporation | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Mahavadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.